Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial
DiscussionResults from this study will be instrumental for the evidence-based care of patients undergoing bariatric surgery.Trial registrationClinicalTrials.gov NCT04742010. Registered on 5 February 2021. (Source: Trials)
Source: Trials - October 8, 2022 Category: Research Source Type: clinical trials

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study
Condition:   Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis Intervention:   Other: Non-intervention Sponsor:   Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials